Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome

NCT04940572 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Wolfram Syndrome

Interventions

DRUG: Depakine

Sponsor

Centre d'Etude des Cellules Souches

Collaborators

[object Object]